 Vasodilator Agents
"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in this website by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 1 | 1 | | 1987 | 1 | 1 | 2 | | 1988 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles.
-
Abais JM, Xia M, Li G, Chen Y, Conley SM, Gehr TW, Boini KM, Li PL. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia. J Biol Chem. 2014 Sep 26; 289(39):27159-68.
-
Macdonald RL, Jaja B, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J. SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. Transl Stroke Res. 2013 Jun; 4(3):286-96.
-
Xia M, Zhang C, Boini KM, Thacker AM, Li PL. Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin. Cardiovasc Res. 2011 Feb 01; 89(2):401-9.
-
Wong GK, Poon WW. Re: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity (Prevedello DM et al. Surg Neurol 2006;65:S1:14-S1:21). Surg Neurol. 2006 Jul; 66(1):110; author reply 110-1.
-
Macaluso C, Frishman LJ, Frueh B, Kaelin-Lang A, Onoe S, Niemeyer G. Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina. Doc Ophthalmol. 2003 Jan; 106(1):51-9.
-
Grady RE, Strickland RA, Fabi AY, Murray MJ. Intraoperative use of nitric oxide during intracranial aneurysm clipping in a patient with acute respiratory distress syndrome. J Neurosurg Anesthesiol. 1999 Apr; 11(2):124-6.
-
Jacinto SM, Lokhandwala MF, Jandhyala BS. Effect of pharmacological interventions in the prevention of lipid peroxidation and respiratory depression induced by oxygen free radicals in anesthetized rats. Free Radic Biol Med. 1996; 21(6):791-9.
-
Cooper JA, Hill SJ, Alexander SP, Rubin PC, Horn EH. Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets. Br J Clin Pharmacol. 1995 Jul; 40(1):43-50.
-
Alexander SP, Curtis AR, Kendall DA, Hill SJ. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Br J Pharmacol. 1994 Dec; 113(4):1501-7.
-
Alexander SP, Losinski A, Kendall DA, Hill SJ. A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta. Br J Pharmacol. 1994 Jan; 111(1):185-90.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|